Artemisinin-independent inhibitory activity of Artemisia sp. infusions against different Plasmodium stages including relapse-causing hypnozoites

Archive ouverte

Ashraf, Kutub | Tajeri, Shahin | Arnold, Christophe-Sébastien | Amanzougaghene, Nadia | Franetich, Jean-François | Vantaux, Amélie | Soulard, Valérie | Bordessoulles, Mallaury | Cazals, Guillaume | Bousema, Teun | van Gemert, Geert-Jan | Le Grand, Roger | Dereuddre-Bosquet, Nathalie | Witkowski, Benoît | Witkowski, Benoit | Snounou, Georges | Duval, Romain | Botté, Cyrille, y | Mazier, Dominique

Edité par CCSD ; Life Science Alliance LLC -

International audience. Artemisinin-based combination therapies (ACT) are the frontline treatments against malaria worldwide. Recently the use of traditional infusions from Artemisia annua (from which artemisinin is obtained) or Artemisia afra (lacking artemisinin) has been controversially advocated. Such unregulated plant-based remedies are strongly discouraged as they might constitute suboptimal therapies and promote drug resistance. Here, we conducted the first comparative study of the anti-malarial effects of both plant infusions in vitro against the asexual erythrocytic stages of Plasmodium falciparum and the preerythrocytic (i.e., liver) stages of various Plasmodium species. Low concentrations of either infusion accounted for significant inhibitory activities across every parasite species and stage studied. We show that these antiplasmodial effects were essentially artemisinin-independent and were additionally monitored by observations of the parasite apicoplast and mitochondrion. In particular, the infusions significantly incapacitated sporozoites, and for Plasmodium vivax and P. cynomolgi, disrupted the hypnozoites. This provides the first indication that compounds other than 8-aminoquinolines could be effective antimalarials against relapsing parasites. These observations advocate for further screening to uncover urgently needed novel antimalarial lead compounds.

Suggestions

Du même auteur

Chloroquine Potentiates Primaquine Activity against Active and Latent Hepatic Plasmodia Ex Vivo : Potentials and Pitfalls

Archive ouverte | Dembélé, Laurent | CCSD

International audience. For a long while, 8-aminoquinoline compounds have been the only therapeutic agents against latent hepatic malaria parasites. These have poor activity against the blood-stage plasmodia causing...

Chloroquine Potentiates Primaquine Activity against Active and Latent Hepatic Plasmodia Ex Vivo: Potentials and Pitfalls

Archive ouverte | Dembélé, Laurent | CCSD

International audience. For a long while, 8-aminoquinoline compounds have been the only therapeutic agents against latent hepatic malaria parasites. These have poor activity against the blood-stage plasmodia causing...

A New Thienopyrimidinone Chemotype Shows Multistage Activity against Plasmodium falciparum, Including Artemisinin-Resistant Parasites

Archive ouverte | Bosson-Vanga, Henriette | CCSD

International audience. Human malaria infection begins with a one-time asymptomatic liver stage followed by a cyclic symptomatic blood stage. For decades, the research for novel antimalarials focused on the high-thr...

Chargement des enrichissements...